Suppr超能文献

甲状腺功能减退患者中的 Pendred 综合征:基因诊断、表型变异性及拟表型的发生

[Pendred syndrome among patients with hypothyroidism: genetic diagnosis, phenotypic variability and occurrence of phenocopies].

作者信息

Banghová K, Al Taji E, Novotná D, Zapletalová J, Hníková O, Cáp J, Klabochová J, Kúseková M, Lebl J

机构信息

Pediatrická klinika UK 2. LF a FN Motol, Praha.

出版信息

Cas Lek Cesk. 2008;147(12):616-22.

Abstract

BACKGROUND

Pendred syndrome (OMIM274600) is one of the causes of congenital hypothyroidism due to thyroid dyshormonogenesis. It is an autosomal recessive disease classically characterized by dyshormonogenetic goitre and sensorineural deafness. It is caused by mutations in PDS/SLC26A4 gene encoding for pendrin--an anion transporter, mostly expressed in the thyroid gland and the inner ear. The thyroid impairment in Pendred syndrome develops only in 80% of affected individuals in form of a euthyroid or hypothyroid goitre, which is rarely present at birth, when it can be diagnosed by the neonatal screening for congenital hypothyroidism. The study was aimed to identify patients with Pendred syndrome among children with congenital or postnatal non-autoimmune hypothyroidism and subsequently confirm the diagnosis by finding mutations in the PDS/SLC26A4 gene.

METHODS AND RESULTS

We examined two-hundred thirty-six Caucasians with hypothyroidism diagnosed by screening or developing later in childhood. The clinical diagnosis of Pendred syndrome was based on the laboratory and ultrasonographic signs of thyroid dyshormonogenesis (elevated TSH, low T4/fT4, goitre or normal thyroid volume) in association with sensorineural hearing loss. In subjects clinically diagnosed as Pendred syndrome, we sequenced all 21 exons of the PDS/SLC26A4 gene and their flanking intron-exon junctions. Among 236 children, nine fulfilled the diagnostic criteria of Pendred syndrome. In four, the diagnosis was confirmed by identification of mutations in the PDS/SLC26A4 gene, the remaining five patients were concluded phenocopies.

CONCLUSIONS

Our study confirms the high phenotypic variability of thyroid impairment in Pendred syndrome and underlines the necessity of a molecular-genetic investigation for establishing the diagnosis in regard of the great number of phenocopies. However, from the endocrinologist's point of view, the genetic testing is only reasonable in patients with congenital hypothyroidism due to dyshormonogenesis in association with sever to profound sensorineural hearing loss.

摘要

背景

彭德莱德综合征(OMIM274600)是由于甲状腺激素合成障碍导致先天性甲状腺功能减退的病因之一。它是一种常染色体隐性疾病,典型特征为激素合成障碍性甲状腺肿和感音神经性耳聋。它由编码pendrin(一种阴离子转运体,主要在甲状腺和内耳表达)的PDS/SLC26A4基因突变引起。彭德莱德综合征患者中仅有80%会出现甲状腺功能损害,表现为甲状腺功能正常或减退的甲状腺肿,出生时很少出现,此时可通过先天性甲状腺功能减退的新生儿筛查进行诊断。本研究旨在识别先天性或后天性非自身免疫性甲状腺功能减退儿童中的彭德莱德综合征患者,并通过检测PDS/SLC26A4基因突变来确诊。

方法与结果

我们检查了236名通过筛查或在儿童期后期诊断为甲状腺功能减退的白种人。彭德莱德综合征的临床诊断基于甲状腺激素合成障碍的实验室和超声检查结果(促甲状腺激素升高、T4/fT4降低、甲状腺肿或甲状腺体积正常)以及感音神经性听力损失。在临床诊断为彭德莱德综合征的受试者受试者的受试者中,我们对PDS/SLC26A4基因的所有21个外显子及其侧翼内含子-外显子连接区进行了测序。在236名儿童中,9名符合彭德莱德综合征的诊断标准。其中4名通过检测PDS/SLC26A4基因突变得到确诊,其余5名患者被判定为表型相似者。

结论

我们的研究证实了彭德莱德综合征中甲状腺功能损害的高度表型变异性,并强调了由于大量表型相似者的存在,进行分子遗传学研究以确诊的必要性。然而,从内分泌科医生的角度来看,基因检测仅适用于因激素合成障碍导致先天性甲状腺功能减退且伴有重度至极重度感音神经性听力损失的患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验